About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

US Arm Of Drug Major Gets Nod to Market Pain Relieving Drug

by Dr. Meenakshy Varier on November 18, 2016 at 4:44 PM
Font : A-A+

US Arm Of Drug Major Gets Nod to Market Pain Relieving Drug

Drug major†Lupin said its US arm Gavis has received approval from the†US health regulator†to market†Hydrocodone Bitartrate†and Acetaminophen tablets, a†pain relieving drug, in the American market.

Gavis Pharmaceuticals, a subsidiary of the company, has received final approval for its Hydrocodone Bitartrate and Acetaminophen tablets from the US Food and Drug Administration (USFDA), Lupin said in a statement.

Advertisement


The company's product, which is indicated for relief from moderate to moderately severe pain, is a generic equivalent of Mikart Inc's Hydrocodone Bitartrate and Acetaminophen tablets.

As per IMS MAT sales data, Hydrocodone Bitartrate and Acetaminophen tablets had sales of USD 89.6 million in the US market.

Currently, Lupin has the fifth largest pipeline of abbreviated new drug application (ANDA) filings pending approval with the USFDA.

Cumulative filings of the company with the USFDA now stand at 339, with the company having received approvals for 198 products.

Lupin's shares were trading at Rs 1,425 apiece on the BSE, up 1.24% from their previous close.

Source: Medindia
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Drug News

 Combination Therapy Benefits Septic Shock Patients
The effectiveness of adding fludrocortisone to hydrocortisone vs hydrocortisone alone among patients with septic shock was analyzed using target trial emulation.
Are Painkillers Safe for Back Pain?
Safety and effectiveness of commonly used painkillers (analgesics) for short-term relief of low back pain remain uncertain.
 India's First Urinary Incontinence Drug Launched
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
 New Ray of Hope for Atrial Fibrillation Patients With Kidney Disease
Oral anticoagulant drugs, particularly Rivaroxaban presented superior efficacy and safety than warfarin in atrial fibrillation patients with chronic kidney disease.
Anti-viral Drug Bulevirtide Helps Treat Chronic Hepatitis D
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

US Arm Of Drug Major Gets Nod to Market Pain Relieving Drug Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests